Financial reports
10-Q
2025 Q1
Quarterly report
15 Aug 24
NT 10-Q
Notice of late quarterly filing
14 Aug 24
10-K
2024 FY
Annual report
17 Jul 24
NT 10-K
Notice of late annual filing
28 Jun 24
10-Q
2024 Q3
Quarterly report
20 Feb 24
NT 10-Q
Notice of late quarterly filing
14 Feb 24
10-Q
2024 Q2
Quarterly report
21 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-Q
2024 Q1
Quarterly report
15 Aug 23
Current reports
8-K
Entry into a Material Definitive Agreement
12 Sep 24
8-K
Unregistered Sales of Equity Securities
20 Oct 23
8-K
Departure of Directors or Certain Officers
16 Oct 23
8-K
Entry into a Material Definitive Agreement
19 Sep 23
8-K
Departure of Directors or Certain Officers
21 Jun 23
8-K
Entry into a Material Definitive Agreement
7 Oct 22
8-K
Alterola Biotech Signs Letter of Intent with Bright Green for Strategic Partnership to Advance Development of Pharmaceutical-Grade Cannabis
1 Sep 22
8-K
Alterola Biotech Inc. (OTC Markets ABTI) Announces Stop Transfer Legend Application to certain shares on its Shareholder Register
6 Jul 22
8-K
Departure of Directors or Certain Officers
18 May 22
8-K
Departure of Directors or Certain Officers
10 May 22
Registration and prospectus
Proxies
No filings
Other
UPLOAD
Letter from SEC
20 Sep 22
CORRESP
Correspondence with SEC
14 Sep 22
UPLOAD
Letter from SEC
12 Sep 22
UPLOAD
Letter from SEC
1 Aug 22
EFFECT
Notice of effectiveness
21 Apr 22
CORRESP
Correspondence with SEC
18 Apr 22
UPLOAD
Letter from SEC
15 Apr 22
EFFECT
Notice of effectiveness
1 Nov 21
CORRESP
Correspondence with SEC
26 Oct 21
UPLOAD
Letter from SEC
26 Oct 21